Page last updated: 2024-10-19

2,3,4,5-tetrahydroxypentanal and Breast Neoplasms

2,3,4,5-tetrahydroxypentanal has been researched along with Breast Neoplasms in 2 studies

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Wang, L1
Zhao, L1
Gong, FL1
Sun, C1
Du, DD1
Yang, XX1
Guo, XL1
Salehi, F1
Jamali, T1
Kavoosi, G1
Ardestani, SK1
Vahdati, SN1

Other Studies

2 other studies available for 2,3,4,5-tetrahydroxypentanal and Breast Neoplasms

ArticleYear
Modified citrus pectin inhibits breast cancer development in mice by targeting tumor-associated macrophage survival and polarization in hypoxic microenvironment.
    Acta pharmacologica Sinica, 2022, Volume: 43, Issue:6

    Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Female; Glucose; Humans; Hypoxia; Mice; Pectins; Tumor

2022
Stabilization of Zataria essential oil with pectin-based nanoemulsion for enhanced cytotoxicity in monolayer and spheroid drug-resistant breast cancer cell cultures and deciphering its binding mode with gDNA.
    International journal of biological macromolecules, 2020, Dec-01, Volume: 164

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA; DNA D

2020